Author:
Iglarz Marc,Bossu Alexandre,Wanner Daniel,Bortolamiol Céline,Rey Markus,Hess Patrick,Clozel Martine
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference19 articles.
1. The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist;Bolli;J Med Chem,2012
2. A new method for continuous chronic measurement and recording of blood pressure, heart rate, and activity in the rat via radiotelemetry;Brockway;Clin Exp Hypertens A,1991
3. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist;Clozel;J Pharmacol Exp Ther,1994
4. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats;Emoto;Hypertension,2005
5. Why are circulating concentrations of endothelin-1 so low?;Frelin;Cardiovasc Res,1994
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献